Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...
UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.10% of ...
Mumbai: UBS is in discussions to establish an Indian wealth management joint venture with Mumbai-based 360 One WAM, Reuters ...
Most wealthy investors are considering changes in their portfolios ahead of the Nov. 5 U.S. presidential election, according ...
Mexico’s peso is set to strengthen through the first half of next year as investors grow more comfortable with the new ...
UBS analyst Charles Eden maintained a Buy rating on Symrise (0G6T – Research Report) today and set a price target of €139.00. The ...
Swiss bank UBS is running around six months ahead of schedule in its cost savings efforts and its integration of Credit ...
Novartis (SIX: NOVN), and other stocks could present surprises to investors during the third quarter earnings season, as per ...
UBS Group AG is reiterating its commitment to the Asia-Pacific region and particularly to China, as the bank still sees it as ...